Skip to content

Federal at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$2.72M-70.1%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:CurrentFederalTaxExpenseBenefit.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's federal?
QuidelOrtho Corporation (QDEL) reported federal of -$375K in Q4 2025.
How has QuidelOrtho Corporation's federal changed year-over-year?
QuidelOrtho Corporation's federal decreased by 36.4% year-over-year, from -$275K to -$375K.
What is the long-term trend for QuidelOrtho Corporation's federal?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's federal has grown at a -82.6% compound annual growth rate (CAGR), from -$49.3M to -$1.5M.
What does federal mean?
The portion of the total income tax provision that is payable to the national government for the current reporting period. It reflects the immediate cash tax impact of domestic operations based on taxable income.